Abstract
Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Current Respiratory Medicine Reviews
Title:Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment
Volume: 11 Issue: 1
Author(s): Delphine Engel and Riyad Karmy-Jones
Affiliation:
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Abstract: Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Export Options
About this article
Cite this article as:
Engel Delphine and Karmy-Jones Riyad, Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706144638
DOI https://dx.doi.org/10.2174/1573398X1101150706144638 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Olfactory Dysfunction and Cognitive Impairment in Age-Related Neurodegeneration: Prevalence Related to Patient Selection, Diagnostic Criteria and Therapeutic Treatment of Aged Clients Receiving Clinical Neurology and Community-Based Care
Current Clinical Pharmacology Infectious Burden: A New Risk Factor and Treatment Target for Atherosclerosis
Infectious Disorders - Drug Targets Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies
Current Aging Science Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
Current Medicinal Chemistry Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?
Current Molecular Pharmacology In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Small Molecules that Promote Neurogenesis in vitro
Recent Patents on CNS Drug Discovery (Discontinued) Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions
Current Drug Metabolism Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Cyclooxygenases Regulation by Estradiol on Endothelium
Current Pharmaceutical Design Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research The Ambidextrous Cyclooxygenase: An Enduring Target
Inflammation & Allergy - Drug Targets (Discontinued) Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders
CNS & Neurological Disorders - Drug Targets Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Therapeutic Gene Products Delivery by Neuron Stem Cells
Current Pharmaceutical Biotechnology Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Clinical Application of Ghrelin
Current Pharmaceutical Design Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Inhibition of Early Biochemical Defects in Prodromal Huntington’s disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients
Current Aging Science